EUVIMEDEUVIMED entdecken
Open Access

Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis

Angel Moreno, Jordan Mah, Indre Budvytiene, Dora Y Ho, Hayden T Schwenk, Niaz Banaei iD

Journal of Clinical Microbiology · 2024

DOI: 10.1128/jcm.00394-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Angel Moreno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Mucormycosis, Cell-Free Nucleic Acids, Polymerase Chain Reaction, DNA, Fungal. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspergillus species and Mucorales agents are the primary etiologies of invasive fungal disease (IFD). Biomarkers that predict outcomes are needed to improve care. Patients diagnosed with invasive aspergillosis and mucormycosis using plasma cell-free DNA (cfDNA) PCR were retested weekly for 4 weeks. The primary outcome included all-cause mortality at 6 weeks and 6 months based on baseline cycle threshold (CT) values and results of follow-up cfDNA PCR testing. Forty-five patients with Aspergillus and 30 with invasive Mucorales infection were retested weekly for a total of 197 tests. Using the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSG) criteria, 30.7% (23/75), 25.3% (19/75), and 38.7% (29/75) had proven, probable, and possible IFD, respectively. In addition, 97.3% (73/75) were immunocompromised. Baseline CT increased significantly starting at week 1 for Mucorales and week 2 for Aspergillus . Aspergillosis and mucormycosis patients with higher baseline CT (CT >40 and >35, respectively) had a nonsignificantly higher survival rate at 6 weeks, compared with patients with lower baseline CT. Mucormycosis patients with higher baseline CT had a significantly higher survival rate at 6 months. Mucormycosis, but not aspergillosis patients, with repeat positive cfDNA PCR results had a nonsignificantly lower survival rate at 6 weeks and 6 months compared with patients who reverted to negative. Aspergillosis patients with baseline serum Aspergillus galactomannan index

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucormycosisCell-Free Nucleic AcidsPolymerase Chain ReactionDNA, FungalInvasive Fungal InfectionsHumansMaleFemaleMiddle AgedPrognosisAgedAdultAspergillusAspergillosisMucoralesBiomarkersAged, 80 and overProspective Studies

Stichwörter der Autor:innen

AspergillosisPCRcell-freecfDNAmucormycosisplasma

Substanzen

Cell-Free Nucleic AcidsDNA, FungalBiomarkers

Autor:innen und Institutionen

  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Clinical Microbiology Laboratory, Stanford Health Care, Palo Alto, California, USA.
  • Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA.
  • Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Niaz Banaei

Zitieren

APA

Moreno, A., Mah, J., Budvytiene, I., Ho, D. Y., Schwenk, H. T., & Banaei, N. (2024). Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00394-24

Vancouver

Moreno A, Mah J, Budvytiene I, Ho DY, Schwenk HT, Banaei N. Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00394-24

BibTeX
@article{Moreno2024,
  author = {Moreno, Angel and Mah, Jordan and Budvytiene, Indre and Ho, Dora Y and Schwenk, Hayden T and Banaei, Niaz},
  title = {Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  doi = {10.1128/jcm.00394-24}
}
Kostenlos starten →